NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Exploratory/Developmental Program for Translational Research in Muscular Dystrophy (R21)
Release Date: March 7, 2006
Announcement Number: PAR-06-203
Application Receipt Date:
June 1, 2006

Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Child Health and Human Development (NICHD) solicit applications for translational research projects in muscular dystrophy. Several emerging pathways to treatment of muscular dystrophy show promise, ranging from palliative therapies that can markedly delay onset or progression of the disease to genetic or stem cell approaches that may reverse or eliminate the condition. The objective of this initiative is to encourage the pursuit of a broad range of translational research strategies for therapeutic development in muscular dystrophy. This Funding Opportunity Announcement (FOA) solicits exploratory/developmental applications that will provide the leads, tools, and resources needed for a subsequent therapy development project. Applications are encouraged for translational research exploratory/developmental projects for any one or more of the muscular dystrophies.

Choose an option to view additional funding announcements